Naruto, Japan

Ryuji Sakakibara

This inventor holds 1 USPTO granted patent. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryuji Sakakibara. Retrieved from https://idiyas.com/inventor/ryuji-sakakibara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryuji Sakakibara: Innovator in Pharmaceutical Chemistry

Introduction

Ryuji Sakakibara is a notable inventor based in Naruto, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on N-substituted guanidino acid derivatives. His research has implications for the development of anti-inflammatory agents.

Latest Patents

Ryuji Sakakibara holds a patent for N-substituted guanidino acid derivatives. This patent describes a compound with a specific formula where R is an alkyl, cycloalkyl, or arylalkyl group. The compounds exhibit excellent pharmacological activities, particularly in antagonism to bradykinin and histamine, making them useful as anti-inflammatory agents. He has 1 patent to his name.

Career Highlights

Sakakibara is associated with Taiho Pharmaceutical Company Limited, where he has been instrumental in advancing pharmaceutical research. His work has contributed to the development of new therapeutic agents that address various medical conditions.

Collaborations

Ryuji Sakakibara has collaborated with notable colleagues such as Sadao Hashimoto and Yasushi Kurashige. These collaborations have fostered a productive research environment, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Ryuji Sakakibara's contributions to pharmaceutical chemistry highlight his role as an inventor dedicated to improving healthcare through innovative compounds. His work continues to influence the development of effective anti-inflammatory agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…